Key Record Dates
ClinicalTrials.gov Identifier: | NCT02978625 |
---|---|
Brief Title: | Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers |
First Submitted : | November 30, 2016 |
First Submitted that Met QC Criteria : | November 30, 2016 |
First Posted : | December 1, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | March 20, 2024 |
Last Update Posted : | March 21, 2024 |